All Airrosti providers adhere to a disciplined approach that focuses on quality and results.
What really differentiates Airrosti in the health care space isn’t as much what we do, but rather how we do it. Our unyielding commitment to quality care and a dedicated focus on evidence-based medicine allows us to achieve such remarkable and consistent outcomes for our patients. We always do what’s in the best interest of our patients, and we hold ourselves accountable to getting measurable treatment results. Our rigorous Quality Care Standards are detailed below:
Before our providers are admitted into our training program, they must undergo and clear all of the following:
Before practicing, all our providers complete a minimum of 5-6 weeks of intensive training at the Airrosti Clinical Development Center. This includes hours of hands-on training, classroom time, as well as patient clinics that comprise no less than half of their training time. The result is providers with a strong mix of professional excellence as well as critical patient skills.
Our provider analysis doesn’t end when training is over. Based on patient feedback and individual provider metrics, the Airrosti Clinical Development Team provides ongoing management and coaching to maintain our high level of quality and delivery of results. We also maintain quality assurance through the following processes and systems:
Time spent with each patient is critical to rendering an accurate orthopedic diagnosis, potential differential diagnosis, and any possible contraindications. Therefore we place great emphasis on patient quality time in order to perform a complete medical history, evaluation, and assessment of the following functions:
To ensure safe and effective care, detailed clinical documentation is an integral part of the Airrosti practice. Providers must adhere to HIPAA policies, guidelines, and security rules related to all clinical documentation.
Our treatment model is built on medical necessity, especially as it relates to cost-effectiveness. Our providers are required to closely monitor patient improvement and adherence to medical necessity through outcome data analysis and episodic claims review. Treatment is only prescribed when a significant therapeutic improvement over a clearly defined period of time is present.
Testing is performed with best clinical judgment to establish or support the diagnosis or for the necessary treatment of the patient; decisions are based on documented clinical guideline contraindications.
Soft tissue and joint mobilization is delivered through a hands-on approach (manual therapy), using skilled manual/physical medicine to effect changes in the soft tissues (including muscles, connective tissue as well as fascial tissue, and joint structures) with the purpose of improving function and range of motion.
Active care includes methods of treatment requiring active involvement, participation and responsibility on the part of the patient. Individualized active care will be supervised in-office, and the patient may be provided with instructions for home self-care. Active care in each phase of treatment only begins when the treating provider deems it appropriate to do so. This is based upon, among other things, the severity of the injury, the injured area, the patient’s age, and other limiting factors.
All patients are fully educated on their diagnosis and treatment options. Airrosti providers will explain reasonable expectations for the resolution of symptoms as well as for the patient’s return to work or other activities. Providers are required to document all aspects of active care. Self-care is reinforced with the patient through specific provider-prescribed instruction and exercises.
To ensure that positive progress is occurring, each visit ends with post-treatment functional testing to measure the patient’s demonstrable improvement.
Treatment plans always include quantifiable, attainable short-term and long-term goals and documented progress toward significant functional gains and / or improved activity tolerances. If a contraindication or medical red flag is present, the patient will be referred to the proper specialist. Treatment planning is prescribed solely on an outcome basis, not by benefit design or allowable visits.
Based on clinical findings, differential diagnosis occurs when two or more conditions with similar symptoms to the chief complaint are present. The Airrosti provider will perform a systematic comparison and contrasting of the clinical findings.
Prior to treatment, the patient is evaluated for any underlying conditions that, based on the provider’s licensure, experience and expertise, would modify or contradict the procedure.
Clinical directors engage in ongoing systematic review of the evidence supporting the diagnosis and treatment planning for a condition by clinicians and patients. When new guidelines and evidence emerge that improve quality and/or results, the clinical team incorporates appropriate clinical guideline changes. In short, we’re always getting better so our patients get optimal results.
Airrosti Providers are committed to obtaining outcome responses after every patient visit. This provides data for real-time reporting on patient results, cost efficiency, and ROI relative to actual claims data. Episodic claims analyses are routinely performed to validate our outcome-based care is both effective and efficient.